Benzinga's Top Upgrades

Benchmark Company upgraded Hess Corporation

from “sell” to “buy.” Hess' shares closed at $60.21 yesterday. Hess' PEG ratio is 0.64. Analysts at Credit Suisse upgraded Allergan Inc

from “neutral” to “outperform.” AGN's shares closed at $74.75 yesterday. Allergan's trailing-twelve-month revenue is $5.21 billion. Analysts at Piper Jaffray upgraded Alnylam Pharmaceuticals Inc

from “neutral” to “overweight.” ALNY's shares closed at $7.34 yesterday. Alnylam Pharmaceuticals had $217.95 million in total cash for the recent quarter. Analysts at Morgan Keegan upgraded Cal Dive International Inc

from “market perform” to “outperform.” DVR's shares closed at $3.01 yesterday. Cal Dive International's trailing-twelve-month revenue is $574.30 million.